Shanmugamurthy Lakshmanan
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shanmugamurthy Lakshmanan.
European Journal of Nanomedicine | 2013
Pinar Avci; Gaurav K. Gupta; Shanmugamurthy Lakshmanan; Rakkiyappan Chandran; Ying-Ying Huang; Raj Kumar; Michael R. Hamblin
Abstract Photodynamic therapy (PDT) employs the combination of non-toxic photosensitizers (PS) together with harmless visible light of the appropriate wavelength to produce reactive oxygen species that kill unwanted cells. Because many PS are hydrophobic molecules prone to aggregation, numerous drug delivery vehicles have been tested to solubilize these molecules, render them biocompatible and enhance the ease of administration after intravenous injection. The recent rise in nanotechnology has markedly expanded the range of these nanoparticulate delivery vehicles beyond the well-established liposomes and micelles. Self-assembled nanoparticles are formed by judicious choice of monomer building blocks that spontaneously form a well-oriented 3-dimensional structure that incorporates the PS when subjected to the appropriate conditions. This self-assembly process is governed by a subtle interplay of forces on the molecular level. This review will cover the state of the art in the preparation and use of self-assembled liposomal nanoparticles within the context of PDT.
Nano Reviews | 2015
Michael R. Hamblin; Long Y. Chiang; Shanmugamurthy Lakshmanan; Ying-Ying Huang; María García-Díaz; Mahdi Karimi; Alessandra Nara de Souza Rastelli; Rakkiyappan Chandran
Abstract The research interests of the Hamblin Laboratory are broadly centered on the use of different kinds of light to treat many different diseases. Photodynamic therapy (PDT) uses the combination of dyes with visible light to produce reactive oxygen species and kill bacteria, cancer cells and destroy unwanted tissue. Likewise, UV light is also good at killing especially pathogens. By contrast, red or near-infrared light can have the opposite effect, to act to preserve tissue from dying and can stimulate healing and regeneration. In all these applications, nanotechnology is having an ever-growing impact. In PDT, self-assembled nano-drug carriers (micelles, liposomes, etc.) play a great role in solubilizing the photosensitizers, metal nanoparticles can carry out plasmon resonance enhancement, and fullerenes can act as photosensitizers, themselves. In the realm of healing, single-walled carbon nanotubes can be electrofocused to produce nano-electonic biomedical devices, and nanomaterials will play a great role in restorative dentistry.
IEEE Transactions on Terahertz Science and Technology | 2017
Saravana Prakash Thirumuruganandham; Edgar A. Gómez; Shanmugamurthy Lakshmanan; Michael R. Hamblin
Infrared (IR) and terahertz (THz) spectroscopy simulations were carried out using CHARMM35b2 to determine protein stability. The stabilities of three hyperthermophilic cold shock proteins (Csps) originating from mesophiles, thermophiles, and hyper-thermophiles, respectively, were investigated in this study. The three different Csps were investigated by normal-mode analysis and molecular dynamics simulation of THz spectra using the Hessian matrix for solvated systems, interpreted in the harmonic approximation at optimum near-melting temperatures of each homologue, by incorporating differences in the hydrous and anhydrous states of the Csps. The results show slight variations in the large-scale protein motion. However, the IR spectra of Csps observed at the low-frequency saddle surface region, clearly distinguishes the thermophilic and mesophilic proteins based on their stability. Further studies on protein stability employing low-frequency collective modes have the potential to reveal functionally important conformational changes that are biologically significant.
Advanced Drug Delivery Reviews | 2014
Shanmugamurthy Lakshmanan; Gaurav K. Gupta; Pinar Avci; Rakkiyappan Chandran; Ana Elisa Serafim Jorge; Michael R. Hamblin
Current Pharmaceutical Design | 2015
Tanupriya Agrawal; Pinar Avci; Gaurav K. Gupta; Ardeshir Rineh; Shanmugamurthy Lakshmanan; Vincent Batwala; George P. Tegos; Michael R. Hamblin
Ancient Science | 2015
Divya Krishnakumar; Michael R. Hamblin; Shanmugamurthy Lakshmanan
Archive | 2015
Shanmugamurthy Lakshmanan; Michael R. Hamblin
Archive | 2015
Shanmugamurthy Lakshmanan; Michael R. Hamblin
Archive | 2015
Shanmugamurthy Lakshmanan; Michael R. Hamblin
Archive | 2015
Shanmugamurthy Lakshmanan; Michael R. Hamblin
Collaboration
Dive into the Shanmugamurthy Lakshmanan's collaboration.
Saravana Prakash Thirumuruganandham
University of Alabama at Birmingham
View shared research outputs